Abstract

The main objective of this paper is to develop and validate flow injection method, a precise, accurate, simple, economic, low cost and specific turbidimetric method for the quantitative determination of mebeverine hydrochloride (MbH) in pharmaceutical preparations. A homemade NAG Dual & Solo (0-180º) analyser which contains two identical detections units (cell 1 and 2) was applied for turbidity measurements. The developed method was optimized for different chemical and physical parameters such as perception reagent concentrations, aqueous salts solutions, flow rate, the intensity of the sources light, sample volume, mixing coil and purge time. The correlation coefficients (r) of the developed method were 0.9980 and 0.9986 for cell 1 and 2 respectively and showed the linearity of response against concentration over the range of 1.0 to 6.5 and 0.7-6.5mmol/L for cell 1 & 2 respectively. The limit of detections (LOD) for cell 1 and cell 2 were 0.28 and 0.21 mmol/L respectively. The intra-day and inter-day precision for two serial estimations of 3.5 and 5.5 mmol/L of MBH exhibited a relative standard deviation of 0.46%, 0.28%, 0.23%, 0.26% and 0.39%, 0.79%, 0.14%, 0.05% for cell 1 & 2 respectively. The accuracy of the developed method has expressed a recovery percentage (Rec %) and error % which was between 99.22 to 101.13 and 99.39 to 101.17 for cell 1 and cell 2 respectively. The ICH guidelines were followed for method validation. The developed method was successfully applied for the determination of MbH in pure and pharmaceutical preparations and the method can be conveniently used for routine analysis in laboratory as a quality control method since the method permits quantitively determination of 60 samples/h.

Highlights

  • Mebeverine hydrochloride (MbH) is a musculotropic antispasmodic drug without any side effects on the normal gut motility

  • The proposed method for the determination of MbH was optimized by using different aqueous salts, varying of Phosphomolybdic acid (PMA) reagent concentrations, flow rates, light intensities, mixing coils, purge time and sample volumes

  • The optimized method consists of line no 1 which is the carrier stream, line no 2 which is the PMA reagent 15 mmol/L, flow rates (2.80 & 3.30 ml/min) for stream-line and reagent line respectively, light intensity (I=1, 5) for cell 1 and 2 respectively, open valve mode for the purge time and 200 uL as a sample volume

Read more

Summary

Introduction

Mebeverine hydrochloride (MbH) is a musculotropic antispasmodic drug without any side effects on the normal gut motility. It is chemically known as 4-[Ethyl-[1-(4-methoxyphenyl) propan-2yl] amino] butyl 3,4- dimethoxybenzoate hydrochloride (Fig. 1). Irritable bowel syndrome (IBS) and gastrointestinal spasm are mainly treated by Mebeverine hydrochloride 1-3. Its action on the smooth muscle of the colon is to reveal spasm with normal gut motility 4. It represents the most prescribed drug which is currently available for treating gastrointestinal spasm and irritable bowel syndrome 5-7. In 2000, the MbH was officially registered in the British Pharmacopoeia 8

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call